Bill > SB878

This bill modifies provisions related to pharmaceutical drugs and devices, primarily by establishing new limits on the sale and purchase of over-the-counter medications containing ephedrine, phenylpropanolamine, or pseudoephedrine, which are commonly used to produce methamphetamine. It sets daily, thirty-day, and twelve-month limits on the total amount of these substances an individual can purchase or acquire, and also specifies limits for pharmacists, intern pharmacists, and registered pharmacy technicians. The bill also expands the scope of pharmacy practice by allowing pharmacists to prescribe certain medical devices and to order and administer vaccines under specific conditions, and it permits pharmacists to dispense ivermectin and hydroxychloroquine without a prescription under certain protocols. Additionally, it prohibits health carriers and pharmacy benefit managers from discriminating against covered entities that dispense drugs purchased under the 340B drug-pricing program, requires health benefit plans to cover nonopioid pain medications over opioids, and mandates coverage for home blood pressure monitoring devices and services for pregnant or postpartum women. Finally, it establishes a fee for manufacturers of pseudoephedrine-containing products to fund a real-time electronic tracking system.